{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:52:36Z","timestamp":1791460356958,"version":"4.3.4"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yrtph.2026.106195","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:36:00Z","timestamp":1785220560000},"page":"106195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A quantitative weight-of-evidence review of preclinical studies examining the potential carcinogenicity of acetaminophen"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-3290","authenticated-orcid":false,"given":"Michael","family":"Kovochich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-3958","authenticated-orcid":false,"given":"Michael D.","family":"Southall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaff","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Kumar","family":"Pitchaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jacobson-Kram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-8250","authenticated-orcid":false,"given":"Daniel G.","family":"Kougias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"49","key":"10.1016\/j.yrtph.2026.106195_bib1","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1016\/j.tet.2012.09.098","article-title":"DPPH radical scavenging activity of paracetamol analogues","volume":"68","author":"Alisi","year":"2012","journal-title":"Tetrahedron"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.joca.2006.10.008","article-title":"Three-month efficacy and safety of acetaminophen extended-release for osteoarthritis pain of the hip or knee: a randomized, double-blind, placebo-controlled study","volume":"15","author":"Altman","year":"2007","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1265\/jjh.40.567","article-title":"Subchronic and chronic effects of feeding of large amounts of acetaminophen in B6C3F1 mice","volume":"40","author":"Amo","year":"1985","journal-title":"Nihon Eiseigaku Zasshi"},{"key":"10.1016\/j.yrtph.2026.106195_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yrtph.2017.02.017","article-title":"Quantitative weight of evidence to assess confidence in potential modes of action","volume":"86","author":"Becker","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"10","key":"10.1016\/j.yrtph.2026.106195_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analyzing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2026.106195_bib7","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.yrtph.2017.10.010","article-title":"Framework for the quantitative weight-of-evidence analysis of 'omics data for regulatory purposes","volume":"91","author":"Bridges","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106195_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10937404.2016.1200505","article-title":"Quantitative weight-of-evidence analysis of the persistence, bioaccumulation, toxicity, and potential for long-range transport of the cyclic volatile methyl siloxanes","volume":"19","author":"Bridges","year":"2016","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.yrtph.2026.106195_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2021.102036","article-title":"Analgesic use and the risk of renal cell carcinoma \u2013 findings from the consortium for the investigation of renal malignancies (CONFIRM) study","volume":"75","author":"Bruinsma","year":"2021","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.yrtph.2026.106195_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101155","article-title":"High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype","volume":"64","author":"Bryan","year":"2025","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.123.001772","article-title":"High-dose acetaminophen with concurrent CYP2E1 inhibition has profound anticancer activity without liver toxicity","volume":"388","author":"Bryan","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"19","key":"10.1016\/j.yrtph.2026.106195_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194770","article-title":"High-dose acetaminophen with N-acetylcysteine rescue inhibits M2 polarization of tumor-associated macrophages","volume":"15","author":"Bryan","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ijc.28093","article-title":"Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies","volume":"134","author":"Choueiri","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yrtph.2026.106195_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yrtph.2019.01.017","article-title":"Chemical carcinogenicity revisited 3: risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans","volume":"103","author":"Cohen","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106195_bib13","first-page":"1398","article-title":"Effect of p-Hydroxyacetanilide, sodium sulfate, and L-Methionine on the leukemogenicity of N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide","volume":"38","author":"Cohen","year":"1978","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106195_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.annemergmed.2006.05.015","article-title":"Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains","volume":"48","author":"Dalton","year":"2006","journal-title":"Ann. Emerg. Med."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.annemergmed.2004.05.005","article-title":"Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion","volume":"44","author":"Daly","year":"2004","journal-title":"Ann. Emerg. Med."},{"issue":"11","key":"10.1016\/j.yrtph.2026.106195_bib17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00586-008-0783-x","article-title":"A systematic review of paracetamol for non-specific low back pain","volume":"17","author":"Davies","year":"2008","journal-title":"Eur. Spine J."},{"issue":"11","key":"10.1016\/j.yrtph.2026.106195_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/0024-3205(74)90092-7","article-title":"Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen","volume":"14","author":"Davis","year":"1974","journal-title":"Life Sci."},{"issue":"178","key":"10.1016\/j.yrtph.2026.106195_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/oxfordjournals.qjmed.a067458","article-title":"Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage","volume":"45","author":"Davis","year":"1976","journal-title":"Q. J. Med."},{"key":"10.1016\/j.yrtph.2026.106195_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104499","article-title":"Tetrahydrofuran-induced tumors in rodents are not relevant to humans: quantitative weight of evidence analysis of mode of action information does not support classification of tetrahydrofuran as a possible human carcinogen","volume":"109","author":"Dekant","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106195_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yrtph.2017.08.012","article-title":"A quantitative weight of evidence assessment of confidence in modes-of-action and their human relevance","volume":"90","author":"Dekant","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106195_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yrtph.2016.09.009","article-title":"A quantitative weight of evidence methodology for the assessment of reproductive and developmental toxicity and its application for classification and labeling of chemicals","volume":"82","author":"Dekant","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106195_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.yrtph.2016.09.032","article-title":"Assessment of reproductive and developmental effects of DINP, DnHP and DCHP using quantitative weight of evidence","volume":"81","author":"Dekant","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib24","first-page":"173","article-title":"The effects of iodinated glycerol, trichlorfon, and acetaminophen on tumor progression in a Fischer rat leukemia transplant model","volume":"16","author":"Dieter","year":"1992","journal-title":"Cancer Detect. Prev."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106195_bib25","article-title":"Guidance on the use of the weight of evidence approach in scientific assessments","volume":"15","year":"2017","journal-title":"EFSA J."},{"key":"10.1016\/j.yrtph.2026.106195_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104788","article-title":"Application of the DILIsym(R) quantitative systems toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen","volume":"118","author":"Eichenbaum","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/tcm.1770100205","article-title":"Tumor promotion: models and assay systems","volume":"10","author":"Fitzgerald","year":"1990","journal-title":"Teratog. Carcinog. Mutagen."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0344-0338(78)80034-X","article-title":"Effects of chronic oral dosing with quinine sulphate in the rat","volume":"163","author":"Flaks","year":"1978","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.yrtph.2026.106195_bib33","first-page":"367","article-title":"Induction by paracetamol of bladder and liver tumours in the rat. Effects on hepatocyte fine structure","volume":"93","author":"Flaks","year":"1985","journal-title":"Acta Pathol. Microbiol. Immunol. Scand. A"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106195_bib32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/carcin\/4.9.1117","article-title":"An electron microscope study of hepatocellular changes in the rat during chronic treatment with acetamide. Parenchyma, foci and neoplasms","volume":"4","author":"Flaks","year":"1983","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/carcin\/3.1.103","article-title":"Effects of prolonged oral treatment with N-fluoren-4-ylacetohydroxamic acid on rat liver fine structure","volume":"3","author":"Flaks","year":"1982","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106195_bib28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/carcin\/3.9.981","article-title":"3-Methylcholanthrene-inhibition of hepatocarcinogenesis in the rat due to 3'-methyl-4-dimethylaminoazobenzene or 2-acetylamino-fluorene: a comparative study","volume":"3","author":"Flaks","year":"1982","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/carcin\/4.4.363-a","article-title":"Induction of liver cell tumours in IF mice by paracetamol","volume":"4","author":"Flaks","year":"1983","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib34","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1002\/jcp.29221","article-title":"Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2\/heme oxygenase-1 signaling pathway in non-small-cell lung cancer","volume":"235","author":"Gai","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yrtph.2004.11.001","article-title":"Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?","volume":"41","author":"Gaylor","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.yrtph.2026.106195_bib36","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.clpt.6100121","article-title":"Disposition of acetaminophen at 4, 6, and 8 g\/day for 3 days in healthy young adults","volume":"81","author":"Gelotte","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2026.106195_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2020.12.029","article-title":"The anti-tumour activity of DNA methylation inhibitor 5-aza-2\u2032-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress","volume":"501","author":"Gleneadie","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharm"},{"key":"10.1016\/j.yrtph.2026.106195_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yrtph.2017.10.004","article-title":"Weight of evidence approaches for the identification of endocrine disrupting properties of chemicals: review and recommendations for EU regulatory application","volume":"91","author":"Gross","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0272-0590(86)90087-4","article-title":"The chronic hepatotoxic, tumor-promoting, and carcinogenic effects of acetaminophen in male B6C3F1 mice","volume":"7","author":"Hagiwara","year":"1986","journal-title":"Fund. Appl. Toxicol."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106195_bib41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/10408444.2019.1701985","article-title":"Effects of atrazine on fish, amphibians, and reptiles: update of the analysis based on quantitative weight of evidence","volume":"49","author":"Hanson","year":"2019","journal-title":"Crit. Rev. Toxicol."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106195_bib42","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. Roy. Soc. Med."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib43","first-page":"79","article-title":"Carcinogenicity testing of acetaminophen in F344 rats","volume":"76","author":"Hiraga","year":"1985","journal-title":"Jpn. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1293\/tox.1.193","article-title":"Effects of nephrotoxic compounds on renal- and hepato-carcinogenesis of rats","volume":"1","author":"Hirose","year":"1988","journal-title":"J. Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030432","article-title":"PET\/CT imaging of c-Myc transgenic mice identifies the genotoxic N-Nitroso-Diethylamine as carcinogen in a short-term cancer bioassay","volume":"7","author":"Hueper","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yrtph.2026.106195_bib46","series-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans: pharmaceutical drugs","year":"1990"},{"key":"10.1016\/j.yrtph.2026.106195_bib47","series-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","first-page":"683","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","year":"1999"},{"key":"10.1016\/j.yrtph.2026.106195_bib48","first-page":"590","article-title":"Report of the advisory group to recommend priorities for the IARC monographs during 2025\u20132029","year":"2024","journal-title":"Int. Agen. Res. Cancer"},{"key":"10.1016\/j.yrtph.2026.106195_bib49","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"S1A the need for long-term rodent carcinogenicity studies of pharmaceuticals","year":"1996"},{"key":"10.1016\/j.yrtph.2026.106195_bib50","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"S1C(R2) - dose selection for carcinogenicity studies of pharmaceuticals","year":"2008"},{"key":"10.1016\/j.yrtph.2026.106195_bib51","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"S1B(R1)- testing for carcinogenicity of pharmaceuticals","year":"2022"},{"issue":"7","key":"10.1016\/j.yrtph.2026.106195_bib52","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1158\/1055-9965.EPI-11-0210","article-title":"A large cohort study of long-term acetaminophen use and prostate cancer incidence","volume":"20","author":"Jacobs","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.yrtph.2026.106195_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104859","article-title":"Assessment of the biochemical pathways for acetaminophen toxicity: implications for its carcinogenic hazard potential","volume":"120","author":"Jaeschke","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/CCM.0000000000000718","article-title":"Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the acetaminophen for the reduction of oxidative injury in severe sepsis trial","volume":"43","author":"Janz","year":"2015","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ijc.2910270416","article-title":"Carcinogenicity of analgesics: long-term treatment of sprague-dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen)","volume":"27","author":"Johansson","year":"1981","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0192623309356450","article-title":"Commentary: update on animal models for NTP studies","volume":"38","author":"King-Herbert","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2026.106195_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104892","article-title":"A comprehensive weight of evidence assessment of published acetaminophen genotoxicity data: implications for its carcinogenic hazard potential","volume":"122","author":"Kirkland","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2026.106195_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1289\/ehp.94102s1255","article-title":"Dose-response relationship in multistage carcinogenesis: promoters","volume":"102","author":"Kitchin","year":"1994","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/10408444.2024.2442344","article-title":"A quantitative weight-of-evidence review of preclinical studies examining the potential developmental neurotoxicity of acetaminophen","volume":"55","author":"Kougias","year":"2025","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10408444.2024.2446471","article-title":"A quantitative weight-of-evidence review of preclinical studies examining the potential developmental and reproductive toxicity of acetaminophen","volume":"55","author":"Kougias","year":"2025","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3835(86)90110-2","article-title":"Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine","volume":"32","author":"Kurata","year":"1986","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106195_bib62","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/carcin\/8.9.1281","article-title":"Reciprocal modifying effects of isomeric forms of aminophenol on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine","volume":"8","author":"Kurata","year":"1987","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106195_bib63","article-title":"Brief report: acetaminophen reduces neoadjuvant chemoimmunotherapy efficacy in patients with NSCLC by promoting neutrophil extracellular trap formation: analysis from a phase 2 clinical trial","volume":"4","author":"Li","year":"2023","journal-title":"JTO Clin. Res. Rep."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/019262338601400217","article-title":"National toxicology program nomenclature for hepatoproliferative lesions of rats","volume":"14","author":"Maronpot","year":"1986","journal-title":"Toxicol. Pathol."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106195_bib65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/10408444.2016.1174669","article-title":"The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms)","volume":"46","author":"Maronpot","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"issue":"6","key":"10.1016\/j.yrtph.2026.106195_bib66","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/carcin\/11.6.895","article-title":"Lack of hepatocarcinogenic potential of acetaminophen in rats with liver damage associated with a choline-devoid diet","volume":"11","author":"Maruyama","year":"1990","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib67","first-page":"231","article-title":"Inhibitory effects of ethoxyquin, 4,4'-diaminodiphenylmethane and acetaminophen on rat hepatocarcinogenesis","volume":"77","author":"Masui","year":"1986","journal-title":"Jpn. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"issue":"11","key":"10.1016\/j.yrtph.2026.106195_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027197","article-title":"Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety","volume":"6","author":"Mirkovi\u0107","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.yrtph.2026.106195_bib70","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2131\/jts.47.421","article-title":"Investigation of radical scavenging effects of acetaminophen, p-aminophenol and their O-sulfated conjugates","volume":"47","author":"Morita","year":"2022","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106195_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104801","article-title":"A critical review of the acetaminophen preclinical carcinogenicity and tumor promotion data and their implications for its carcinogenic hazard potential","volume":"118","author":"Murray","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JCTI\/2018\/39590","article-title":"Reduction of UV-induced skin tumours in hairless mice by topical non-steroidal anti-inflammatory drugs","volume":"7","author":"Ngo","year":"2018","journal-title":"J. Cancer Tumor Int."},{"key":"10.1016\/j.yrtph.2026.106195_bib73","first-page":"1","article-title":"NTP toxicology and carcinogenesis studies of acetaminophen (CAS No. 103-90-2) in F344 rats and B6C3F1 mice (feed studies)","volume":"394","year":"1993","journal-title":"Natl. Toxicol. Progr. Tech. Rep."},{"key":"10.1016\/j.yrtph.2026.106195_bib74","article-title":"Handbook for conducting a literature-based health assessment using OHAT approach for systematic review and evidence integration. Office of health assessment and translation (OHAT), division of the national toxicology program","year":"2019","journal-title":"Nat. Instit. Environ. Health Sci."},{"key":"10.1016\/j.yrtph.2026.106195_bib75","series-title":"Series on Testing and Assessment No. 35 and Series on Pesticides No. 14: Guidance Notes for Analysis and Evaluation of Chronic Toxicity and Carcinogenicity Studies","year":"2002"},{"key":"10.1016\/j.yrtph.2026.106195_bib76","series-title":"Guidance Document 116 on the Conduct and Design of Chronic Toxicity and Carcinogenicity Studies, Supporting Test Guidelines 451","first-page":"452","year":"2014"},{"key":"10.1016\/j.yrtph.2026.106195_bib77","article-title":"Test No. 453: combined chronic toxicity\/carcinogenicity studies","volume":"4","year":"2018","journal-title":"OECD Guidel. Test. Chem. Sect."},{"key":"10.1016\/j.yrtph.2026.106195_bib79","series-title":"OECD Series on Testing and Assessment, No. 311","article-title":"Guiding principles and key elements for establishing a weight of evidence for chemical assessment","year":"2019"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib80","first-page":"32","article-title":"Effect of small doses of aspirin and acetaminophen on total menstrual loss and pain of cramps and headache","volume":"19","author":"Pendergrass","year":"1985","journal-title":"Gynecol. Obstet. Invest."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib81","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neo.2021.02.001","article-title":"High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity","volume":"23","author":"Pingali","year":"2021","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003495-199448020-00006","article-title":"Pharmacological management of back pain syndromes","volume":"48","author":"Porter","year":"1994","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/path.1711170307","article-title":"Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters","volume":"117","author":"Portmann","year":"1975","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.yrtph.2026.106195_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112429","article-title":"Paracetamol intake and hematologic malignancies: a meta-analysis of observational studies","volume":"10","author":"Prego-Dominguez","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00045391-200007020-00011","article-title":"Paracetamol: past, present, and future","volume":"7","author":"Prescott","year":"2000","journal-title":"Am. J. Therapeut."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib86","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/AJP.0b013e318227cc4f","article-title":"A randomized, placebo-controlled trial of acetaminophen extended release for treatment of post-marathon muscle soreness","volume":"28","author":"Prior","year":"2012","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.yrtph.2026.106195_bib87","article-title":"Paracetamol - an old drug with new mechanisms of action","author":"Przyby\u0142a","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.yrtph.2026.106195_bib88","series-title":"An Introduction to Pharmaceutical Sciences","first-page":"231","article-title":"10 - the top five most common or long-selling drugs","author":"Roy","year":"2011"},{"issue":"12","key":"10.1016\/j.yrtph.2026.106195_bib89","first-page":"38","article-title":"Acetaminophen intoxication: a critical-care emergency","volume":"41","author":"Saljoughian","year":"2016","journal-title":"US Pharm."},{"key":"10.1016\/j.yrtph.2026.106195_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104866","article-title":"Quantifying bias in epidemiologic studies evaluating the association between acetaminophen use and cancer","volume":"120","author":"Schuemie","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib91","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1349-7006.1995.tb03034.x","article-title":"Modification by analgesics of lesion development in the urinary tract and various other organs of rats pretreated with dihydroxy-di-N-propylnitrosamine and uracil","volume":"86","author":"Shibata","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.yrtph.2026.106195_bib92","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00204-013-1030-8","article-title":"Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen","volume":"87","author":"Singh","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106195_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104944","article-title":"Comprehensive investigation evaluating the carcinogenic hazard potential of acetaminophen","volume":"123","author":"Sirois","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106195_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111283","article-title":"Paracetamol suppresses neutrophilic oxygen radicals through competitive inhibition and scavenging","volume":"404","author":"Smith","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"6\u20137","key":"10.1016\/j.yrtph.2026.106195_bib95","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/10937404.2017.1388563","article-title":"Quantitative weight of evidence assessment of higher-tier studies on the toxicity and risks of neonicotinoid insecticides in honeybees 1: methods","volume":"20","author":"Solomon","year":"2017","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"6\u20137","key":"10.1016\/j.yrtph.2026.106195_bib96","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10937404.2017.1388567","article-title":"Quantitative weight of evidence assessment of higher tier studies on the toxicity and risks of neonicotinoids in honeybees. 3. Clothianidin","volume":"20","author":"Solomon","year":"2017","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"6\u20137","key":"10.1016\/j.yrtph.2026.106195_bib97","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10937404.2017.1388574","article-title":"Quantitative weight of evidence assessment of risk to honeybee colonies from use of imidacloprid, clothianidin, and thiamethoxam as seed treatments: a postscript","volume":"20","author":"Solomon","year":"2017","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib98","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/rtph.2001.1493","article-title":"IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis","volume":"34","author":"Sonich-Mullin","year":"2001","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6\u20137","key":"10.1016\/j.yrtph.2026.106195_bib99","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10937404.2017.1388564","article-title":"Quantitative weight of evidence assessment of higher-tier studies on the toxicity and risks of neonicotinoids in honeybees. 2. Imidacloprid","volume":"20","author":"Stephenson","year":"2017","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"6\u20137","key":"10.1016\/j.yrtph.2026.106195_bib100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/10937404.2017.1388568","article-title":"Quantitative weight of evidence assessment of higher tier studies on the toxicity and risks of neonicotinoids in honeybees. 4. Thiamethoxam","volume":"20","author":"Stephenson","year":"2017","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib101","first-page":"7","article-title":"Paracetamol supplementation does not alter the antitumor activity and lung toxicity of bleomycin","volume":"2","author":"Suddek","year":"2013","journal-title":"J. Food Pharm. Sci."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106195_bib102","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bcp.2011.02.012","article-title":"Acetaminophen-induced differentiation of human breast cancer stem cells and inhibition of tumor xenograft growth in mice","volume":"81","author":"Takehara","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/adt.2017.838","article-title":"Utility of Resazurin, horseradish peroxidase, and NMR assays to identify redox-related false-positive behavior in high-throughput screens","volume":"16","author":"Tarnowski","year":"2018","journal-title":"Assay Drug Dev. Technol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106195_bib104","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clinthera.2006.02.004","article-title":"Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis","volume":"28","author":"Temple","year":"2006","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/carcin\/5.4.525","article-title":"Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine","volume":"5","author":"Tsuda","year":"1984","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yrtph.2026.106195_bib106","series-title":"Guidelines for Carcinogen Risk Assessment. EPA\/630\/P-03\/001F","year":"2005"},{"key":"10.1016\/j.yrtph.2026.106195_bib109","series-title":"Center for Drug Evaluation and Research: Application No.: 022450Orig1S000. Pharmacology Review(S). Supervisor's Secondary Review","year":"2010"},{"key":"10.1016\/j.yrtph.2026.106195_bib110","series-title":"Comments on Notice of Availability of Hazard Identification Materials for Acetaminophen","year":"2019"},{"key":"10.1016\/j.yrtph.2026.106195_bib111","first-page":"14","article-title":"Comment submissions - announcement of the carcinogen identification committee meeting scheduled for December 5, 2019, notice of availability of hazard identification materials for acetaminophen and notice of public comment period","year":"2019","journal-title":"US Food Drug Administr. (FDA) Cent. Drug Eval. Res. (CDER) Resp. Docum. Re: Select. Acetaminoph. Consid. List. Carcin. Identif. Comm."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib112","first-page":"193","article-title":"Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL\/6 mice","volume":"35","author":"Vad","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"Suppl. 5","key":"10.1016\/j.yrtph.2026.106195_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2014.967836","article-title":"Effects of atrazine in fish, amphibians, and reptiles: an analysis based on quantitative weight of evidence","volume":"44","author":"Van Der Kraak","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106195_bib114","series-title":"Quantitative Bias Assessment to Facilitate Assessment of (Un)Certainty in Observational Data Evaluating Acetaminophen Use and Liver Cancer","author":"Vincent","year":"2026"},{"issue":"12","key":"10.1016\/j.yrtph.2026.106195_bib115","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1158\/1055-9965.EPI-11-0709","article-title":"Cancer risk associated with long-term use of acetaminophen in the prospective VITamins and lifestyle (VITAL) study","volume":"20","author":"Walter","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"17","key":"10.1016\/j.yrtph.2026.106195_bib116","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2011.34.6346","article-title":"Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective vitamins and lifestyle (VITAL) study","volume":"29","author":"Walter","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib117","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0041-008X(88)90009-9","volume":"96","author":"Ward","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106195_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105043","article-title":"A systematic assessment of the epidemiologic literature regarding an association between acetaminophen exposure and cancer","volume":"127","author":"Weinstein","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib119","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jnci\/51.1.235","article-title":"Effect of acetanilide and p-hydroxyacetanilide on the carcinogenicity of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in mice, hamsters, and female rats","volume":"51","author":"Weisburger","year":"1973","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.yrtph.2026.106195_bib120","first-page":"1411","article-title":"Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies","volume":"27","author":"Weiss","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.yrtph.2026.106195_bib121","article-title":"Global assessment of the state-of-the-science of endocrine disruptors","year":"2002","journal-title":"Int. Progr. Chem. Saf."},{"key":"10.1016\/j.yrtph.2026.106195_bib122","series-title":"Principles and Methods for the Risk Assessment of Chemicals in Food","year":"2009"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106195_bib124","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.1780360904","article-title":"Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee","volume":"36","author":"Williams","year":"1993","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106195_bib123","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008469-199708000-00007","article-title":"Inhibition by acetaminophen of intestinal cancer in rats induced by an aromatic amine similar to food mutagens","volume":"6","author":"Williams","year":"1997","journal-title":"Eur. J. Cancer Prev."},{"issue":"Suppl. 3","key":"10.1016\/j.yrtph.2026.106195_bib125","first-page":"89","article-title":"Clinical management of young patients presenting with headache","volume":"15","author":"Wober","year":"2000","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.yrtph.2026.106195_bib126","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yrtph.2019.01.021","article-title":"Chemical carcinogenicity revisited 1: a unified theory of carcinogenicity based on contemporary knowledge","volume":"103","author":"Wolf","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.yrtph.2026.106195_bib127","first-page":"2391","article-title":"Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma","volume":"33","author":"Wu","year":"2013","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106195_bib128","first-page":"454","article-title":"Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide","volume":"33","author":"Yamamoto","year":"1973","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106195_bib129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-016-0781-6","article-title":"Acetaminophen attenuates lipopolysaccharide-induced cognitive impairment through antioxidant activity","volume":"14","author":"Zhao","year":"2017","journal-title":"J. Neuroinflammation"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:07:56Z","timestamp":1791457676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":126,"alternative-id":["S0273230026001686"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106195","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A quantitative weight-of-evidence review of preclinical studies examining the potential carcinogenicity of acetaminophen","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106195"}}